関連する実験動画
Updated: Feb 14, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
1.1K
PDE7Aの廃止は,EMT誘発性肺線維症によるアルベオラ上皮質の改善を図る
Jianqiang Guo1, Jiawei Zhou1, Anqi Cheng1
1School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China; Key Laboratory of Industrial Dust Deep Reduction and Occupational Health and Safety of Anhui Higher Education Institutes, AUST, Huainan 232001, China.
Biochemical pharmacology
|February 12, 2026
まとめ
BRL-50481はフォスフォディエステラーゼ7A (PDE7A) を標的とし,上皮質-メゼンキマ移行 (EMT) を阻害し,イディオパシー性肺線維症 (IPF) の線維症を軽減します. この研究は,PDE7AAを明らかにしています.
科学分野:
- 肺内医学は肺内医学である.
- 細胞生物学 細胞生物学
- 薬理学 薬理学とは
背景:
- エピセリアル-メゼンキマトランジション (EMT) は,イディオパシー性肺線維症 (IPF) を駆動する.
- 限られた治療法は,IPFにおける上皮細胞を標的とする.
- IPFとEMTにおけるフォスフォディエステラーゼ7A (PDE7A) の役割はほとんど不明である.
研究 の 目的:
- BRL-50481.1.の抗線維性効果を調査する.
- BRL-50481.1の分子標的としてPDE7Aを識別する.
- 皮質細胞線維症とEMTの調節におけるPDE7Aのメカニズムを解明する.
主な方法:
- バイオインフォマティックスクリーニングでBRL-50481.1が特定されました.
- ブレオミシン誘発のネズミ線維症およびTGF-β誘発のA549細胞モデルで有効性を試験した.
- 分子ドッキング,CETSA,およびミュータゲネシスによる薬物標的相互作用が確認され,下流経路が検証されました.
主要な成果:
- PDE7Aは,IPFのアルベオラ上皮細胞で高度に発現しています.
- BRL-50481はPDE7Aと結合し,JAK2 / STAT3シグナリングを阻害する.
- 阻害はEMT,炎症,コラーゲン堆積を抑制し,肺線維症を緩和しました.
結論:
- PDE7Aは,アルベオラ上皮細胞におけるJAK2/STAT3シグナル伝達とEMTの主要な調節体である.
- BRL-50481は,PDE7A/JAK2/STAT3経路を標的にすることで,抗線維性効果を発揮する.
- これは,新しいPDE7Aを標的としたIPF療法のための理論的基礎を提供します.
関連する概念動画
01:26Alveoli and Alveolar Ducts
6.0K
The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
6.0K
01:23Cystic Fibrosis: Pathogenesis
896
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
896
01:24Cystic Fibrosis: Management
549
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
549
01:27ATP Driven Pumps I: An Overview
10.0K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
10.0K
01:29Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
01:28Pulmonary Tuberculosis II
1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K